Harrow Inc (HROW)
43.88
+1.44
(+3.39%)
USD |
NASDAQ |
Nov 21, 16:00
43.58
-0.30
(-0.68%)
After-Hours: 20:00
Harrow Total Liabilities (Quarterly): 293.92M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 293.92M |
| June 30, 2024 | 248.45M |
| March 31, 2024 | 235.33M |
| December 31, 2023 | 241.75M |
| September 30, 2023 | 210.66M |
| June 30, 2023 | 201.94M |
| March 31, 2023 | 195.97M |
| December 31, 2022 | 130.14M |
| September 30, 2022 | 98.13M |
| June 30, 2022 | 92.67M |
| March 31, 2022 | 87.86M |
| December 31, 2021 | 87.40M |
| September 30, 2021 | 86.57M |
| June 30, 2021 | 84.12M |
| March 31, 2021 | 28.38M |
| December 31, 2020 | 30.65M |
| September 30, 2020 | 34.54M |
| June 30, 2020 | 34.06M |
| March 31, 2020 | 31.86M |
| December 31, 2019 | 31.67M |
| September 30, 2019 | 30.97M |
| June 30, 2019 | 30.16M |
| March 31, 2019 | 29.48M |
| December 31, 2018 | 24.70M |
| September 30, 2018 | 23.84M |
| Date | Value |
|---|---|
| June 30, 2018 | 22.60M |
| March 31, 2018 | 21.12M |
| December 31, 2017 | 21.30M |
| September 30, 2017 | 22.46M |
| June 30, 2017 | 19.95M |
| March 31, 2017 | 20.56M |
| December 31, 2016 | 20.82M |
| September 30, 2016 | 18.68M |
| June 30, 2016 | 16.44M |
| March 31, 2016 | 16.52M |
| December 31, 2015 | 15.52M |
| September 30, 2015 | 12.78M |
| June 30, 2015 | 11.61M |
| March 31, 2015 | 3.169M |
| December 31, 2014 | 2.092M |
| September 30, 2014 | 2.124M |
| June 30, 2014 | 1.835M |
| March 31, 2014 | 0.6555M |
| December 31, 2013 | 0.6506M |
| September 30, 2013 | 1.058M |
| June 30, 2013 | 1.108M |
| March 31, 2013 | 0.8485M |
| December 31, 2012 | 0.7096M |
| September 30, 2012 | 0.6698M |
| June 30, 2012 | 0.4912M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
28.38M
Minimum
Mar 2021
293.92M
Maximum
Sep 2024
124.30M
Average
90.26M
Median
Total Liabilities (Quarterly) Benchmarks
| Calidi Biotherapeutics Inc | 16.46M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 351.54M |
| Shareholders Equity (Quarterly) | 57.98M |
| Debt to Equity Ratio | 3.209 |
| Current Ratio | 1.548 |
| Net Debt Paydown Yield | -0.20% |